Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.66 |
| ▸ | HTT | P42858 | 1/20 | 0.66 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.66 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.66 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.54 |
| ▸ | CCR3 | P51677 | 1/20 | 0.51 |
| ▸ | DPP4 | P27487 | 1/20 | 0.49 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.49 |
| ▸ | CTSL | P07711 | 2/20 | 0.49 |
| ▸ | CTSB | P07858 | 2/20 | 0.49 |
| ▸ | CTSS | P25774 | 2/20 | 0.49 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.49 |
| ▸ | CTSC | P53634 | 2/20 | 0.48 |
| ▸ | MME | P08473 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3753174 | 0.84 | RIPK1 (0.50) | ALDH1A1HTTNCOA1SMN1; SMN2NCOA3 | |
| SCHEMBL13051427 | 0.84 | RIPK1 (0.50) | ALDH1A1HTTNCOA1SMN1; SMN2NCOA3 | |
| SCHEMBL6217606 | 0.83 | ALDH1A1 (0.52) | ALDH1A1SMN1; SMN2MCL1DPP4DPP8 | |
| SCHEMBL864058 | 0.81 | USP9X (0.48) | ALDH1A1HTTNCOA1SMN1; SMN2NCOA3 | |
| SCHEMBL864059 | 0.81 | USP9X (0.48) | ALDH1A1HTTNCOA1SMN1; SMN2NCOA3 | |
| SCHEMBL365234 | 0.80 | MME (0.65) | MCL1CTSLCTSBCTSSMME | |
| SCHEMBL16889096 | 0.80 | ALDH1A1 (0.71) | ALDH1A1HTTNCOA1SMN1; SMN2NCOA3 | |
| SCHEMBL6813188 | 0.80 | ALDH1A1 (0.71) | ALDH1A1HTTNCOA1SMN1; SMN2NCOA3 | |
| SCHEMBL6318822 | 0.79 | TSHR (0.56) | ALDH1A1MCL1 | |
| Hydrochloric Acid SCHEMBL6813768 | 0.78 | ALDH1A1 (0.69) | ALDH1A1HTTNCOA1SMN1; SMN2NCOA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050059657-A1 | Aminoisoxazole derivatives active as kinase inhibitors | PFIZER ITALIA S.R.L. (IT) | 2005-03-17 | — | — | US | disclosed |
| EP-1435948-A1 | AMINOISOXAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS | Pharmacia Italia S.p.A. (IT) | 2004-07-14 | — | — | EP | disclosed |
| WO-2003013517-A1 | AMINOISOXAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS | PHARMACIA ITALIA S.P.A. (IT) | 2003-02-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050059657-A1 | Aminoisoxazole derivatives active as kinase inhibitors | MAP3K9, MAP3K19, MAP4K2 | ALDH1A1 4444/4885HTT 2134/4885NCOA1 757/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.